Kathryn Lougheed - Concepedia

Author

Kathryn Lougheed

Also Known As

K.E.A. Lougheed, Kathryn E Lougheed, Kathryn E. A. Lougheed, Kathryn E. Lougheed, Kathryn E.A. Lougheed, Kathryn Lougheed

Publications

736

Citations

H-Index

Concepts

All Affiliations

Imperial College London LifeArc University of Leicester The Francis Crick Institute

About

Kathryn Lougheed is an author at Imperial College London specializing in medicine, microbiology, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	433
2	Natural Sciences	2	2	159
3	Health Sciences	1	1	31
4	Biochemistry	1	1	79
5	Cell Biology	1	1	100

Kathryn Lougheed

Publications

726

Citations

H-Index

Page 1

	Year	Citations
A Two-Component Regulator of Universal Stress Protein Expression and Adaptation to Oxygen Starvation in<i>Mycobacterium smegmatis</i> Ronan O’Toole, Marjan J. Smeulders, Marian C. J. Blokpoel, Journal of Bacteriology	2003	104
The Dormancy Regulator DosR Controls Ribosome Stability in Hypoxic Mycobacteria Andrej Trauner, Kathryn Lougheed, Mark H. Bennett, Journal of Biological Chemistry Pulmonary TuberculosisRibosomal DimersHypoxic MycobacteriaMicrobial PathogensMicrobial Proteomics	2012	100
New anti-tuberculosis agents amongst known drugs Kathryn Lougheed, Debra L. Taylor, Simon A. Osborne, Tuberculosis New Anti-tuberculosis AgentsPulmonary TuberculosisMedicineTuberculosis PreventionTuberculosis	2009	87
Individual Mycobacterium tuberculosis universal stress protein homologues are dispensable in vitro Suzie Hingley‐Wilson, Kathryn Lougheed, K M Ferguson, Tuberculosis Medical MicrobiologyPulmonary TuberculosisSystems BiologyNatural SciencesTuberculosis Prevention	2010	80
Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents Kathryn Lougheed, Simon A. Osborne, Barbara Saxty, Tuberculosis Antimicrobial ChemotherapyPharmaceutical ChemistryDrug ResistanceMedicinal ChemistryDrug Discovery Efforts	2011	79
Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype Manish Pareek, Jason T. Evans, John Innes, Thorax	2012	70
The Mucoid Switch in Pseudomonas aeruginosa Represses Quorum Sensing Systems and Leads to Complex Changes to Stationary Phase Virulence Factor Regulation Ben Ryall, Marta Carrara, James E. A. Zlosnik, PLoS ONE Medical MicrobiologyStationary PhaseMucoid SwitchVirulence FactorPathogenesis	2014	56
Induced ectopic expression of <scp>HigB</scp> toxin in <i><scp>M</scp>ycobacterium tuberculosis</i> results in growth inhibition, reduced abundance of a subset of <scp>mRNAs</scp> and cleavage of <scp>tmRNA</scp> Dorothée L. Schuessler, Teresa Cortes, Amanda Fivian-Hughes, Molecular Microbiology	2013	53
Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis Timothy M. Chapman, Nathalie Bouloc, Roger S. Buxton, Bioorganic & Medicinal Chemistry Letters	2012	52
Cmr is a redox-responsive regulator of DosR that contributes to M. tuberculosis virulence Laura J. Smith, Aleksandra Bochkareva, Matthew D. Rolfe, Nucleic Acids Research BacteriologyImmunologyMolecular BiologyRedox-responsive RegulatorDrug Resistance	2017	31

Page 1